Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andre Luiz Lourenco"'
Autor:
Sophia Hernandez, Andre Luiz Lourenco, Evan Calabrese, Tyler York, Alexa Glencer, Spencer Behr, Zhen Jane Wang, Eugene Koay, Charles Craik, Kimberly Kirkwood
Publikováno v:
Journal of Clinical and Translational Science, Vol 4, Pp 141-141 (2020)
OBJECTIVES/GOALS: Pancreatic cysts are comprised of both precancerous mucinous lesions and non-mucinous lesions with minimal malignant potential. Our goal is to improve our ability to classify the type of cyst using a combination of novel radiomic fe
Externí odkaz:
https://doaj.org/article/25eb7ee79e134b8cbff56c2e447e692c
Autor:
André Luiz Lourenço, Shih-Wei Chuo, Markus F. Bohn, Byron Hann, Shireen Khan, Neha Yevalekar, Nitin Patel, Teddy Yang, Lina Xu, Dandan Lv, Robert Drakas, Sarah Lively, Charles S. Craik
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTThe urokinase-type plasminogen activator receptor (uPAR) is an essential regulator for cell signaling in tumor cell proliferation, adhesion, and metastasis. The ubiquitous nature of uPAR in many aggressive cancer types makes uPAR an attractiv
Externí odkaz:
https://doaj.org/article/069d547a08b64d7f92e26a8d69854d53
Autor:
André Luiz Lourenço
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/4adff66a530c48f8b85509bd944d20f9
Autor:
Ning Zhao, Conner Bardine, André Luiz Lourenço, Yung-hua Wang, Yangjie Huang, Simon J. Cleary, David M. Wilson, David Y. Oh, Lawrence Fong, Mark R. Looney, Michael J. Evans, Charles S. Craik
Publikováno v:
ACS Central Science, Vol 7, Iss 10, Pp 1638-1649 (2021)
Externí odkaz:
https://doaj.org/article/855612b3a40e4f52a10ffc43856da1af
Autor:
Natalia Sevillano, Evan M Green, Jörg Votteler, Dong Young Kim, Xuefeng Ren, Bei Yang, Xi Liu, André Luiz Lourenço, James H Hurley, Shauna Farr-Jones, John D Gross, Yifan Cheng, Charles S Craik
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250318 (2021)
Viral infection and pathogenesis is mediated by host protein-viral protein complexes that are important targets for therapeutic intervention as they are potentially less prone to development of drug resistance. We have identified human, recombinant a
Externí odkaz:
https://doaj.org/article/9b4fb5433d13446b97a21331867264a4
Autor:
André Luiz Lourenço, Max Seidy Saito, Luís Eduardo Gomes Dorneles, Gil Mendes Viana, Plínio Cunha Sathler, Lúcia Cruz de Sequeira Aguiar, Marcelo de Pádula, Thaisa Francielle Souza Domingos, Aline Guerra Manssour Fraga, Carlos Rangel Rodrigues, Valeria Pereira de Sousa, Helena Carla Castro, Lucio Mendes Cabral
Publikováno v:
Molecules, Vol 20, Iss 4, Pp 7174-7200 (2015)
The incidence of hematological disorders has increased steadily in Western countries despite the advances in drug development. The high expression of the multi-resistance protein 4 in patients with transitory aspirin resistance, points to the importa
Externí odkaz:
https://doaj.org/article/16d481e62d404d4983b4926b942fd102
Autor:
Efrat T. Harel, Penelope M. Drake, Robyn M. Barfield, Irene Lui, Shauna Farr-Jones, Laura Van’t Veer, Zev J. Gartner, Evan M. Green, André Luiz Lourenço, Yifan Cheng, Byron C. Hann, David Rabuka, Charles S. Craik
Publikováno v:
Antibodies, Vol 8, Iss 4, p 54 (2019)
A promising molecular target for aggressive cancers is the urokinase receptor (uPAR). A fully human, recombinant antibody that binds uPAR to form a stable complex that blocks uPA-uPAR interactions (2G10) and is internalized primarily through endocyto
Externí odkaz:
https://doaj.org/article/7ba679cb5b3b4d9787ad97d8bf10cae8
Autor:
Rebeca Cristina Costa Pereira, André Luiz Lourenço, Luciana Terra, Paula Alvarez Abreu, Valéria Laneuville Teixeira, Helena Carla Castro
Publikováno v:
Marine Drugs, Vol 15, Iss 3, p 79 (2017)
Thrombosis related diseases are among the main causes of death and incapacity in the world. Despite the existence of antithrombotic agents available for therapy, they still present adverse effects like hemorrhagic risks which justify the search for n
Externí odkaz:
https://doaj.org/article/45678a6133e14bde8ce80d276f1cba99